BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 157 filers reported holding BEAM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,020,911 | -18.7% | 541,410 | +8.0% | 0.00% | -20.0% |
Q2 2023 | $16,010,341 | +12.8% | 501,420 | +8.2% | 0.01% | +25.0% |
Q1 2023 | $14,195,861 | -21.3% | 463,614 | +0.5% | 0.00% | -33.3% |
Q4 2022 | $18,035,733 | -16.2% | 461,154 | +2.0% | 0.01% | -25.0% |
Q3 2022 | $21,529,000 | +39.9% | 451,907 | +13.7% | 0.01% | +60.0% |
Q2 2022 | $15,386,000 | -27.6% | 397,449 | +7.2% | 0.01% | -16.7% |
Q1 2022 | $21,254,000 | -23.3% | 370,916 | +6.6% | 0.01% | -25.0% |
Q4 2021 | $27,719,000 | -4.5% | 347,824 | +4.3% | 0.01% | -11.1% |
Q3 2021 | $29,020,000 | -10.3% | 333,520 | +32.6% | 0.01% | -18.2% |
Q2 2021 | $32,363,000 | +84.0% | 251,442 | +14.5% | 0.01% | +83.3% |
Q1 2021 | $17,585,000 | +5.7% | 219,692 | +7.9% | 0.01% | -14.3% |
Q4 2020 | $16,629,000 | +293.8% | 203,682 | +18.8% | 0.01% | +250.0% |
Q3 2020 | $4,223,000 | +82.6% | 171,511 | +107.6% | 0.00% | +100.0% |
Q2 2020 | $2,313,000 | +393.2% | 82,602 | +217.6% | 0.00% | – |
Q1 2020 | $469,000 | – | 26,005 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |